-
EP3875152
European procedure
Extract from the Register of European Patents
EP About this file: EP3875152
| EP3875152 - COMPOSITIONS AND METHODS FOR TARGETED CYTOKINE DELIVERY [Right-click to bookmark this link] | Status | The patent has been granted Status updated on 08.03.2024 Database last updated on 24.07.2024 | |
| Former | Grant of patent is intended Status updated on 20.11.2023 | ||
| Former | Examination is in progress Status updated on 08.07.2022 | ||
| Former | Request for examination was made Status updated on 11.03.2022 | ||
| Former | The application has been published Status updated on 06.08.2021 | Most recent event Tooltip | 29.03.2024 | Change - divisional application(s) | published on 01.05.2024 [2024/18] | Applicant(s) | For all designated states Washington University One Brookings Drive Saint Louis, MO 63130 / US | [2021/36] | Inventor(s) | 01 /
Krupnick, Alexander Sasha c/o Washington University One Brookings Drive St. Louis, MO 63130 / US | 02 /
Lazear, Eric Reed c/o Washington University One Brookings Drive St. Louis, MO 63130 / US | 03 /
Fremont, Daved Henry c/o Washington University One Brookings Drive St. Louis, MO 63130 / US | [2021/36] | Representative(s) | Greaves Brewster LLP Copa House Station Road Cheddar, Somerset BS27 3AH / GB | [2021/36] | Application number, filing date | 21155548.7 | 15.12.2015 | [2021/36] | Priority number, date | US201462091898P | 15.12.2014 Original published format: US 201462091898 P | US201562243829P | 20.10.2015 Original published format: US 201562243829 P | [2021/36] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3875152 | Date: | 08.09.2021 | Language: | EN | [2021/36] | Type: | B1 Patent specification | No.: | EP3875152 | Date: | 10.04.2024 | Language: | EN | [2024/15] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 09.07.2021 | Classification | IPC: | A61P35/00, A61P31/12, C07K14/705, // C07K14/55, A61K38/00, C07K14/005 | [2021/36] | CPC: |
C07K14/55 (EP,US);
A61K47/642 (US);
A61K47/65 (US);
A61P31/12 (EP);
A61P35/00 (EP);
C07K14/005 (EP,US);
A61K38/00 (EP,US);
C07K2299/00 (EP,US);
C07K2319/20 (EP,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/15] |
| Former [2021/36] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Title | German: | ZUSAMMENSETZUNGEN UND VERFAHREN ZUR GEZIELTEN CYTOKINFREISETZUNG | [2021/36] | English: | COMPOSITIONS AND METHODS FOR TARGETED CYTOKINE DELIVERY | [2021/36] | French: | COMPOSITIONS ET MÉTHODES POUR L'ADMINISTRATION CIBLÉE DE CYTOKINES | [2021/36] | Examination procedure | 07.03.2022 | Examination requested [2022/15] | 07.03.2022 | Date on which the examining division has become responsible | 07.07.2022 | Despatch of a communication from the examining division (Time limit: M02) | 15.09.2022 | Reply to a communication from the examining division | 21.11.2023 | Communication of intention to grant the patent | 04.03.2024 | Fee for grant paid | 04.03.2024 | Fee for publishing/printing paid | 04.03.2024 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP15870897.4 / EP3233192 | Divisional application(s) | EP24167783.0 | Fees paid | Renewal fee | 02.06.2021 | Renewal fee patent year 03 | 02.06.2021 | Renewal fee patent year 04 | 02.06.2021 | Renewal fee patent year 05 | 02.06.2021 | Renewal fee patent year 06 | 24.12.2021 | Renewal fee patent year 07 | 29.12.2022 | Renewal fee patent year 08 | 28.12.2023 | Renewal fee patent year 09 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO2012178137 (GILLIES STEPHEN D [US]); | [A]US2014286898 (GAVIN MARC A [US], et al); | [E]WO2016164937 (AMGEN INC [US]); | by applicant | US4241046 | US4394448 | US4529561 | US4755388 | US4828837 | US4925661 | US4954345 | US4957735 | US5043164 | US5064655 | US5077211 | US5264618 |